Covidien Investor Lambasts Deal Over $43B Medtronic Merger
A class member in a stockholder suit over Covidien PLC and Medtronic Inc.'s proposed, $42.9 billion merger objected Friday to the nonmonetary settlement, saying it fails to benefit the class at...To view the full article, register now.
Already a subscriber? Click here to view full article